However, there was no statistical difference in the MEG3 expression between lymph node metastasis group and non‐lymph node metastasis group (Figure 1D) as well as between well differentiation group and moderate/poor differentiation group (Figure 1E). This evidence concerns the gene MEG3 and metastatic malignant neoplasm in the lymph nodes.